Related Experiment Video
Updated: Aug 25, 2026

Measuring Granulocyte and Monocyte Phagocytosis and Oxidative Burst Activity in Human Blood
Published on: September 12, 2016
Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic
Marie Thérèse Labro1, Houria Abdelghaffar, Catherine Babin-Chevaye
1INSERM U479, CHU Xavier Bichat, 75018, Paris, France. labro@bichat.inserm.fr
Abstract:
A classical velocity centrifugation technique was used to study the in vitro uptake of the new ketolide ABT-773 by human polymorphonuclear neutrophils (PMNs) and a myelomonoblastic cell line, PLB-985, which can be differentiated into PMNs under certain culture conditions, compared to that of HMR 3004. ABT-773 was rapidly taken up by PMNs (cellular concentration to extracellular concentration ratio [C/E], about 34 at 30 s and up to 207 at 5 min), and uptake plateaued from 30 to 180 min (C/E, about 300). ABT-773 was accumulated significantly better than HMR 3004 from 5 to 180 min. Nondifferentiated PLB-985 cells (ND-PLB) accumulated significantly less ABT-773 and HMR 3004 than PMNs and PLB-985 cells differentiated into PMNs (D-PLB). Whatever the cell type and in contrast to the results obtained with HMR 3004, ABT-773 was mainly located in the cytosol (about 75%) and was rapidly released from loaded cells (about 40% at 5 min), followed by a plateau, likely owing to avid reuptake. Verapamil and H89, an inhibitor of protein kinase A, increased drug efflux. Uptake was sensitive to external pH, and the activation energy was moderate (about 50 kJ/mol). The existence of an active transport system on the PMN membrane was suggested by the following findings: concentration-dependent and saturable uptake (V(max), about 10,000 ng/2.5 x 10(6) PMNs/5 min; K(m), about 60 microg/ml) the inhibitory effects of PMN activators or inhibitors (phorbol myristate acetate, verapamil, Ni(2+)) and the significantly decreased levels of accumulation by killed cells and cells treated at low temperatures. In addition, various macrolides impaired ABT-773 uptake, contrary to the findings for the quinolone levofloxacin. ND- and D-PLB also presented saturation kinetics that defined an active transport system (V(max) and K(m) values were similar to those obtained with PMNs), but the activation pathway of the carrier system did not seem to be fully functional in ND-PLB. As has been observed with other erythromycin A derivatives, ABT-773 impaired oxidant production by phagocytes in a time- and concentration-dependent manner. These data extend our previous results on the existence of an active transport system common to all macrolides and ketolides, at least in PMNs.
Insights
The novel ketolide ABT-773 is efficiently taken up by human polymorphonuclear neutrophils (PMNs) via an active transport system, accumulating better than HMR 3004. This uptake mechanism is shared by other macrolides and ketolides.
Area of Science:
- Pharmacology
- Cell Biology
- Immunology
Background:
- Ketolides are a class of antibiotics with potential activity against various bacterial infections.
- Understanding the cellular uptake mechanisms of antibiotics is crucial for optimizing their efficacy and predicting their pharmacokinetic profiles.
- Human polymorphonuclear neutrophils (PMNs) are key immune cells involved in combating bacterial infections.
Purpose of the Study:
- To investigate the in vitro uptake kinetics of the novel ketolide ABT-773 by human PMNs and a myelomonoblastic cell line (PLB-985).
- To compare the uptake of ABT-773 with another compound, HMR 3004.
- To elucidate the transport mechanism and cellular localization of ABT-773 within these cells.
Main Methods:
- Classical velocity centrifugation was employed to study drug uptake.
- Cellular concentration to extracellular concentration ratios (C/E) were measured over time.
- Uptake was assessed in differentiated and non-differentiated PLB-985 cells, as well as in PMNs.
- The effects of verapamil, H89, external pH, temperature, and other antibiotics on ABT-773 uptake were evaluated.
Main Results:
- ABT-773 demonstrated rapid uptake by PMNs, reaching a plateau within 5 minutes and accumulating significantly better than HMR 3004.
- Uptake was saturable and concentration-dependent, suggesting an active transport system on the PMN membrane.
- ABT-773 was primarily located in the cytosol and was rapidly released, indicating potential reuptake mechanisms.
- Differentiated PLB-985 cells showed similar uptake kinetics to PMNs, while non-differentiated cells accumulated less drug.
Conclusions:
- An active transport system, common to macrolides and ketolides, is involved in ABT-773 uptake by human PMNs.
- The cellular accumulation and release characteristics of ABT-773 suggest complex transport dynamics.
- These findings contribute to understanding the pharmacokinetics of ketolides and their interaction with immune cells.
More Related Videos
09:09High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019